Quinolone Antimicrobial [EPC]

Quinolone Antimicrobial [EPC] was reported 9869 times

Drugs of the Quinolone Antimicrobial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DIFFUSE LAMELLAR KERATITIS 12 0.2857
1 FIBRIN 10 0.2326
2 KERATITIS FUNGAL 37 0.1779
3 AQUEOUS FIBRIN 9 0.1765
4 LARYNGEAL HAEMATOMA 11 0.1642
5 CORNEAL STRIAE 11 0.1549
6 TYPE 2 LEPRA REACTION 25 0.1337
7 CORNEAL INFILTRATES 39 0.1242
8 ANTERIOR CHAMBER FIBRIN 14 0.1085
9 CORNEAL DEPOSITS 48 0.0645
10 PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION 11 0.0611
11 CORNEAL EPITHELIUM DEFECT 33 0.0568
12 HYPOPYON 45 0.0543
13 TOXIC ANTERIOR SEGMENT SYNDROME 59 0.0541
14 CORNEAL PERFORATION 32 0.0507
15 DELUSION OF REFERENCE 7 0.0504
16 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 9 0.0495
17 CORNEAL THINNING 11 0.0428
18 CORNEAL SCAR 20 0.0398
19 ANTERIOR CHAMBER CELL 28 0.0392
20 ANTERIOR CHAMBER FLARE 9 0.0386
21 CORNEAL GRAFT REJECTION 8 0.0381
22 CORNEAL OEDEMA 83 0.0370
23 RENAL NECROSIS 8 0.0367
24 RETINAL PIGMENT EPITHELIAL TEAR 24 0.0346
25 CORNEAL OPACITY 44 0.0322
26 CORNEAL EROSION 17 0.0315
27 CORNEAL TRANSPLANT 23 0.0294
28 BONE METABOLISM DISORDER 8 0.0266
29 PERIORBITAL PAIN 22 0.0260
30 EYE ABSCESS 7 0.0230
31 ANTICOAGULATION DRUG LEVEL INCREASED 7 0.0218
32 ULCERATIVE KERATITIS 57 0.0208
33 PUNCTATE KERATITIS 19 0.0207
34 PROSTATIC PAIN 8 0.0196
35 CORNEAL DISORDER 43 0.0196
36 EYE ULCER 11 0.0191
37 CLOSTRIDIUM COLITIS 23 0.0189
38 GINGIVAL ULCERATION 14 0.0186
39 ANTERIOR CHAMBER INFLAMMATION 11 0.0185
40 ENDOPHTHALMITIS 111 0.0185
41 EYE INFECTION FUNGAL 7 0.0181
42 EYELID PAIN 35 0.0172
43 PROTHROMBIN TIME RATIO DECREASED 10 0.0160
44 TENDON DISCOMFORT 12 0.0159
45 THERAPEUTIC PRODUCT CROSS-REACTIVITY 14 0.0157
46 KERATITIS 47 0.0154
47 HYPHAEMA 8 0.0153
48 CORNEAL ABRASION 21 0.0153
49 CATARACT NUCLEAR 10 0.0150
50 TENDON PAIN 113 0.0149
51 CATARACT SUBCAPSULAR 9 0.0148
52 NON-CARDIOGENIC PULMONARY OEDEMA 15 0.0142
53 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 14 0.0132
54 HYPERPARATHYROIDISM SECONDARY 33 0.0132
55 CORYNEBACTERIUM INFECTION 7 0.0131
56 VITREOUS OPACITIES 11 0.0130
57 CHRONIC FATIGUE SYNDROME 18 0.0129
58 INTRAOCULAR PRESSURE TEST ABNORMAL 9 0.0128
59 RETINAL VASCULITIS 15 0.0126
60 UPPER AIRWAY OBSTRUCTION 11 0.0124
61 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 40 0.0123
62 VITREOUS HAEMORRHAGE 32 0.0116
63 NEPHROGENIC ANAEMIA 51 0.0110
64 SUPERFICIAL INJURY OF EYE 12 0.0110
65 FOREIGN BODY SENSATION IN EYES 69 0.0108
66 OTITIS EXTERNA 13 0.0106
67 PROSTATITIS 31 0.0102
68 OCULAR TOXICITY 11 0.0100
69 ILLUSION 16 0.0097
70 TENDON DISORDER 63 0.0097
71 EYE INFLAMMATION 90 0.0094
72 EYE PAIN 526 0.0093
73 VASCULAR PURPURA 13 0.0093
74 ENDOCRINE OPHTHALMOPATHY 8 0.0092
75 VITRITIS 17 0.0092
76 DIARRHOEA INFECTIOUS 7 0.0089
77 MUCOSAL EROSION 8 0.0088
78 TENDONITIS 135 0.0087
79 PERIODONTAL DISEASE 12 0.0086
80 CROSS SENSITIVITY REACTION 8 0.0082
81 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 7 0.0079
82 CONJUNCTIVAL OEDEMA 8 0.0078
83 OCULAR DISCOMFORT 87 0.0077
84 TYMPANIC MEMBRANE PERFORATION 13 0.0077
85 CERUMEN IMPACTION 7 0.0076
86 EXTENSOR PLANTAR RESPONSE 7 0.0076
87 CONJUNCTIVAL HYPERAEMIA 27 0.0076
88 EYELID IRRITATION 19 0.0076
89 INTRAOCULAR PRESSURE INCREASED 96 0.0075
90 HYPERMETROPIA 7 0.0074
91 PHOTOPHOBIA 137 0.0073
92 COARCTATION OF THE AORTA 7 0.0072
93 OCULAR HYPERTENSION 14 0.0072
94 ACQUIRED HAEMOPHILIA 7 0.0070
95 OTORRHOEA 12 0.0069
96 RASH MORBILLIFORM 19 0.0068
97 RETINAL OEDEMA 13 0.0068
98 MOTION SICKNESS 13 0.0067
99 OSTEITIS 17 0.0067
100 CYTOLYTIC HEPATITIS 22 0.0066
101 METAMORPHOPSIA 12 0.0065
102 SCLERITIS 10 0.0062
103 EYE INFECTION 70 0.0062
104 DYSAESTHESIA 19 0.0062
105 ATROPHY 12 0.0062
106 RETINAL DEGENERATION 8 0.0062
107 CONJUNCTIVITIS ALLERGIC 9 0.0061
108 SUPERINFECTION 9 0.0060
109 BLEPHARITIS 24 0.0060
110 EYELID MARGIN CRUSTING 17 0.0059
111 INTRA-ABDOMINAL HAEMORRHAGE 14 0.0059
112 EYE DISCHARGE 61 0.0059
113 FIXED ERUPTION 10 0.0058
114 SWELLING OF EYELID 36 0.0057
115 TESTICULAR PAIN 18 0.0057
116 PERIODONTITIS 12 0.0055
117 TOXIC EPIDERMAL NECROLYSIS 82 0.0054
118 TENDON INJURY 20 0.0054
119 CYSTOID MACULAR OEDEMA 10 0.0053
120 ASTIGMATISM 8 0.0053
121 ORAL MUCOSAL ERUPTION 8 0.0052
122 CUTANEOUS VASCULITIS 19 0.0052
123 RETINAL HAEMORRHAGE 37 0.0052
124 PRODUCT CONTAINER SEAL ISSUE 9 0.0052
125 IRIDOCYCLITIS 16 0.0051
126 KERATOPATHY 8 0.0051
127 IRITIS 15 0.0049
128 PSEUDOMEMBRANOUS COLITIS 11 0.0049
129 ESSENTIAL HYPERTENSION 9 0.0049
130 EYE IRRITATION 281 0.0049
131 OTOTOXICITY 9 0.0049
132 MACULAR OEDEMA 27 0.0048
133 EYE OPERATION 22 0.0048
134 VITREOUS FLOATERS 46 0.0047
135 HEPATOSPLENOMEGALY 12 0.0047
136 HENOCH-SCHONLEIN PURPURA 10 0.0046
137 HYPERACUSIS 17 0.0046
138 MUSCLE CONTRACTIONS INVOLUNTARY 16 0.0045
139 MULTIPLE-DRUG RESISTANCE 14 0.0045
140 EAR HAEMORRHAGE 9 0.0044
141 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 10 0.0043
142 COLONIC POLYP 7 0.0042
143 PUSTULE 10 0.0042
144 CATARACT OPERATION 25 0.0042
145 TENDON RUPTURE 52 0.0042
146 CONJUNCTIVAL HAEMORRHAGE 16 0.0042
147 ENTEROBACTER INFECTION 7 0.0042
148 RENAL TUBULAR ACIDOSIS 9 0.0041
149 BICYTOPENIA 8 0.0041
150 PYELONEPHRITIS ACUTE 8 0.0041
151 HYPERAEMIA 8 0.0041
152 OCULAR HYPERAEMIA 192 0.0040
153 HALLUCINATIONS, MIXED 17 0.0040
154 PERSECUTORY DELUSION 10 0.0040
155 TENOSYNOVITIS 11 0.0040
156 REBOUND ACID HYPERSECRETION 12 0.0040
157 ABNORMAL SENSATION IN EYE 17 0.0040
158 EYELID DISORDER 9 0.0039
159 ERYTHEMA OF EYELID 21 0.0039
160 RETINAL DISORDER 10 0.0038
161 END STAGE RENAL DISEASE 70 0.0038
162 PRODUCT PACKAGING DIFFICULT TO OPEN 10 0.0038
163 LACRIMATION INCREASED 115 0.0038
164 OPTIC NEUROPATHY 8 0.0038
165 WEIGHT BEARING DIFFICULTY 10 0.0037
166 HUMAN HERPESVIRUS 6 INFECTION 7 0.0037
167 HORDEOLUM 16 0.0037
168 INSTILLATION SITE PAIN 9 0.0036
169 HYPOGLYCAEMIA 174 0.0036
170 PYELONEPHRITIS 31 0.0036
171 TOXIC SKIN ERUPTION 36 0.0036
172 MEDICATION RESIDUE PRESENT 17 0.0036
173 ANGLE CLOSURE GLAUCOMA 9 0.0035
174 CONJUNCTIVITIS 65 0.0035
175 ECCHYMOSIS 24 0.0035
176 VISUAL ACUITY REDUCED 116 0.0035
177 EYE SWELLING 127 0.0034
178 CHRONIC KIDNEY DISEASE 258 0.0034
179 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 26 0.0033
180 MUSCLE RUPTURE 13 0.0033
181 INTERNATIONAL NORMALISED RATIO INCREASED 95 0.0033
182 EYE OEDEMA 8 0.0033
183 RETINAL TEAR 8 0.0032
184 CARTILAGE INJURY 8 0.0032
185 CATARACT 193 0.0032
186 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 16 0.0032
187 DERMATITIS EXFOLIATIVE 16 0.0032
188 CEREBELLAR SYNDROME 7 0.0032
189 RETINAL ARTERY OCCLUSION 8 0.0032
190 PURPURA 28 0.0032
191 WRONG DRUG ADMINISTERED 28 0.0031
192 CHOLESTASIS 59 0.0031
193 STRABISMUS 9 0.0031
194 HEPATIC CYTOLYSIS 39 0.0031
195 NECROSIS 17 0.0031
196 FOOD INTOLERANCE 11 0.0030
197 MUSCLE ATROPHY 38 0.0030
198 HYPERGLYCAEMIA 108 0.0030
199 RETINAL DETACHMENT 27 0.0029
200 EAR DISCOMFORT 30 0.0029
201 MENINGITIS ASEPTIC 13 0.0029
202 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 11 0.0029
203 ELECTRIC SHOCK SENSATION 8 0.0029
204 NEURALGIA 69 0.0028
205 PERIORBITAL SWELLING 16 0.0028
206 ORTHOPNOEA 9 0.0028
207 AGRANULOCYTOSIS 52 0.0028
208 PRODUCT DELIVERY MECHANISM ISSUE 15 0.0028
209 POLYDIPSIA 11 0.0028
210 BLINDNESS UNILATERAL 39 0.0028
211 ESCHERICHIA SEPSIS 8 0.0028
212 PATHOGEN RESISTANCE 25 0.0027
213 PHOTOPSIA 17 0.0027
214 DRUG RESISTANCE 69 0.0027
215 SKIN HYPERPIGMENTATION 23 0.0027
216 AREFLEXIA 7 0.0026
217 STEVENS-JOHNSON SYNDROME 58 0.0026
218 TYPE I HYPERSENSITIVITY 9 0.0026
219 INFUSION SITE PRURITUS 8 0.0025
220 PRODUCT PHYSICAL CONSISTENCY ISSUE 14 0.0025
221 IMMOBILE 11 0.0025
222 EOSINOPHILIA 44 0.0025
223 DERMATITIS BULLOUS 18 0.0025
224 SKIN EROSION 8 0.0025
225 HAEMOLYTIC ANAEMIA 22 0.0025
226 DEAFNESS NEUROSENSORY 8 0.0024
227 VASCULAR DEVICE INFECTION 11 0.0024
228 OTITIS MEDIA 8 0.0024
229 AORTIC DISSECTION 10 0.0024
230 ANHEDONIA 63 0.0024
231 RASH MACULO-PAPULAR 53 0.0024
232 SLEEP TERROR 10 0.0024
233 HYPERTHERMIA 18 0.0024
234 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 12 0.0024
235 ECONOMIC PROBLEM 35 0.0023
236 HEPATITIS ACUTE 15 0.0023
237 OESOPHAGEAL CANDIDIASIS 9 0.0023
238 HAEMORRHAGE SUBCUTANEOUS 8 0.0023
239 HAEMORRHAGIC DIATHESIS 8 0.0022
240 EPSTEIN-BARR VIRUS INFECTION 14 0.0022
241 FACIAL PAIN 20 0.0022
242 EYELID OEDEMA 26 0.0022
243 BONE LESION 8 0.0022
244 PANIC REACTION 16 0.0022
245 ORAL CANDIDIASIS 29 0.0022
246 ENCEPHALOPATHY 54 0.0022
247 RENAL FAILURE ACUTE 93 0.0022
248 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
249 PRODUCT ADMINISTRATION ERROR 44 0.0022
250 PROTHROMBIN TIME PROLONGED 13 0.0022
251 DRUG DISPENSING ERROR 33 0.0022
252 EAR INFECTION 57 0.0021
253 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 55 0.0021
254 TUBULOINTERSTITIAL NEPHRITIS 40 0.0021
255 CHRONIC SINUSITIS 8 0.0021
256 HEPATOCELLULAR INJURY 30 0.0021
257 DRY EYE 104 0.0021
258 CLOSTRIDIAL INFECTION 7 0.0021
259 DIABETIC RETINOPATHY 7 0.0021
260 RENAL FAILURE 273 0.0021
261 ANAPHYLACTIC REACTION 113 0.0020
262 VISION BLURRED 279 0.0020
263 GLAUCOMA 39 0.0020
264 PATENT DUCTUS ARTERIOSUS 8 0.0020
265 HYPERREFLEXIA 7 0.0020
266 RECALLED PRODUCT ADMINISTERED 19 0.0020
267 HEPATITIS CHOLESTATIC 12 0.0020
268 PRODUCT CONTAINER ISSUE 17 0.0020
269 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 10 0.0020
270 INTRACRANIAL PRESSURE INCREASED 11 0.0020
271 ASPHYXIA 16 0.0020
272 TINNITUS 90 0.0020
273 IMPAIRED HEALING 64 0.0019
274 SYNOVIAL CYST 9 0.0019
275 HYPERURICAEMIA 8 0.0019
276 LOCALISED OEDEMA 9 0.0019
277 ABNORMAL LOSS OF WEIGHT 13 0.0019
278 EAR PAIN 37 0.0019
279 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
280 HEPATITIS 48 0.0019
281 PULMONARY TUBERCULOSIS 8 0.0019
282 ACUTE KIDNEY INJURY 285 0.0019
283 MULTI-ORGAN FAILURE 32 0.0018
284 GAMMA-GLUTAMYLTRANSFERASE INCREASED 41 0.0018
285 TONGUE DISCOLOURATION 8 0.0018
286 ESCHERICHIA INFECTION 15 0.0018
287 POST-TRAUMATIC STRESS DISORDER 12 0.0018
288 BLINDNESS TRANSIENT 13 0.0018
289 DRUG TOXICITY 24 0.0018
290 CEREBRAL ATROPHY 7 0.0018
291 CARDIAC VALVE DISEASE 10 0.0017
292 CACHEXIA 9 0.0017
293 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
294 HERPES VIRUS INFECTION 10 0.0017
295 RENAL TUBULAR NECROSIS 17 0.0017
296 EYE HAEMORRHAGE 23 0.0017
297 FACE OEDEMA 29 0.0017
298 HYPERTRIGLYCERIDAEMIA 10 0.0017
299 HYPOTONIA 17 0.0017
300 HERPES SIMPLEX 11 0.0017
301 MYOSITIS 15 0.0017
302 EYE PRURITUS 56 0.0017
303 TORSADE DE POINTES 13 0.0017
304 MENTAL STATUS CHANGES 46 0.0017
305 HYDROCEPHALUS 9 0.0017
306 FEBRILE BONE MARROW APLASIA 7 0.0016
307 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
308 AORTIC VALVE INCOMPETENCE 7 0.0016
309 JAW DISORDER 9 0.0016
310 ASTHENOPIA 9 0.0016
311 HYPERKERATOSIS 9 0.0016
312 ANOREXIA 21 0.0016
313 PIGMENTATION DISORDER 10 0.0016
314 DIVERTICULUM INTESTINAL 7 0.0016
315 GROIN PAIN 14 0.0016
316 MYOCLONUS 19 0.0016
317 LUNG INFILTRATION 14 0.0016
318 HAEMATOMA 41 0.0016
319 LYMPHOPENIA 22 0.0016
320 ATELECTASIS 15 0.0016
321 ELECTROLYTE IMBALANCE 18 0.0015
322 SKIN NECROSIS 8 0.0015
323 PETECHIAE 16 0.0015
324 MULTIPLE ALLERGIES 12 0.0015
325 HEPATOMEGALY 15 0.0015
326 MALNUTRITION 17 0.0015
327 OSTEOPENIA 23 0.0015
328 TRICUSPID VALVE INCOMPETENCE 12 0.0015
329 HYPERLIPIDAEMIA 18 0.0015
330 BLINDNESS 61 0.0015
331 RHINITIS 12 0.0015
332 SHOCK HAEMORRHAGIC 12 0.0015
333 DECUBITUS ULCER 12 0.0015
334 MUSCULOSKELETAL DISCOMFORT 25 0.0015
335 ENCEPHALITIS 10 0.0014
336 VISUAL IMPAIRMENT 179 0.0014
337 PULMONARY CONGESTION 19 0.0014
338 STREPTOCOCCAL INFECTION 8 0.0014
339 FORMICATION 10 0.0014
340 PRODUCT LEAKAGE 8 0.0014
341 STAPHYLOCOCCAL INFECTION 47 0.0014
342 CANDIDA INFECTION 24 0.0014
343 POLYNEUROPATHY 17 0.0014
344 ELECTROCARDIOGRAM QT PROLONGED 51 0.0014
345 DRUG ERUPTION 25 0.0014
346 RIB FRACTURE 29 0.0014
347 DIVERTICULUM 10 0.0014
348 PRODUCT ADMINISTRATION INTERRUPTED 11 0.0014
349 UVEITIS 19 0.0014
350 NEUROLOGICAL SYMPTOM 8 0.0014
351 EXERCISE TOLERANCE DECREASED 8 0.0014
352 MUSCLE TWITCHING 32 0.0014
353 ENTEROCOLITIS 8 0.0014
354 VISUAL FIELD DEFECT 10 0.0014
355 GENERALISED OEDEMA 17 0.0014
356 TRANSPLANT REJECTION 11 0.0014
357 HAEMATURIA 47 0.0014
358 ASPERGILLUS INFECTION 9 0.0014
359 LIQUID PRODUCT PHYSICAL ISSUE 10 0.0014
360 NEUROPATHY PERIPHERAL 130 0.0014
361 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
362 MUSCLE DISORDER 11 0.0014
363 NERVE INJURY 15 0.0013
364 BACTERAEMIA 16 0.0013
365 SKIN MASS 9 0.0013
366 PLEURISY 8 0.0013
367 EYE DISORDER 44 0.0013
368 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 10 0.0013
369 PHOTOSENSITIVITY REACTION 22 0.0013
370 INGUINAL HERNIA 8 0.0013
371 GASTROENTERITIS 19 0.0013
372 GRAND MAL CONVULSION 12 0.0013
373 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
374 EXTRASYSTOLES 9 0.0013
375 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
376 NEPHROPATHY 12 0.0013
377 PSEUDOMONAS INFECTION 11 0.0013
378 ANURIA 11 0.0013
379 PULMONARY MASS 19 0.0013
380 INFUSION SITE SWELLING 8 0.0013
381 RESPIRATORY DISTRESS 35 0.0013
382 PANIC ATTACK 46 0.0013
383 BLOOD ALBUMIN DECREASED 10 0.0013
384 ACUTE PULMONARY OEDEMA 7 0.0012
385 MYDRIASIS 16 0.0012
386 HYPERCHOLESTEROLAEMIA 12 0.0012
387 INFUSION SITE PAIN 16 0.0012
388 ANAPHYLACTIC SHOCK 32 0.0012
389 MITRAL VALVE INCOMPETENCE 14 0.0012
390 ADRENAL INSUFFICIENCY 15 0.0012
391 HALLUCINATION, VISUAL 26 0.0012
392 VITAMIN D DEFICIENCY 12 0.0012
393 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
394 MEDICATION ERROR 68 0.0012
395 POLYURIA 10 0.0012
396 OSTEONECROSIS OF JAW 30 0.0012
397 BLOOD URINE PRESENT 23 0.0012
398 SKIN LESION 33 0.0012
399 SEASONAL ALLERGY 17 0.0012
400 HALLUCINATION, AUDITORY 19 0.0012
401 PAROSMIA 9 0.0012
402 PANCYTOPENIA 66 0.0012
403 EYELID PTOSIS 12 0.0012
404 ACIDOSIS 9 0.0012
405 SEPTIC SHOCK 51 0.0012
406 RENAL FAILURE CHRONIC 9 0.0012
407 IMPAIRED WORK ABILITY 25 0.0012
408 HYPOALBUMINAEMIA 9 0.0012
409 NERVOUS SYSTEM DISORDER 36 0.0012
410 SLEEP APNOEA SYNDROME 22 0.0012
411 PRODUCT USE COMPLAINT 18 0.0011
412 DERMATITIS CONTACT 13 0.0011
413 SINUS BRADYCARDIA 11 0.0011
414 PAPULE 8 0.0011
415 NASAL DISCOMFORT 9 0.0011
416 RENAL CYST 9 0.0011
417 DIALYSIS 16 0.0011
418 ORAL HERPES 22 0.0011
419 TRANSAMINASES INCREASED 25 0.0011
420 DRUG INTERACTION 178 0.0011
421 DRUG INTOLERANCE 108 0.0011
422 GASTROINTESTINAL INFECTION 10 0.0011
423 RASH PAPULAR 25 0.0011
424 HYPERKALAEMIA 39 0.0011
425 RENAL INJURY 33 0.0011
426 SCAR 19 0.0011
427 ACUTE HEPATIC FAILURE 15 0.0011
428 EMPHYSEMA 11 0.0011
429 MUSCLE INJURY 9 0.0011
430 DISORIENTATION 43 0.0011
431 OSTEOARTHRITIS 46 0.0011
432 CYTOMEGALOVIRUS INFECTION 18 0.0011
433 THROMBOCYTOPENIA 121 0.0011
434 CARDIO-RESPIRATORY ARREST 45 0.0011
435 ATRIAL SEPTAL DEFECT 9 0.0011
436 DIABETES MELLITUS INADEQUATE CONTROL 19 0.0011
437 HAEMODIALYSIS 9 0.0011
438 FIBROMYALGIA 26 0.0011
439 STATUS EPILEPTICUS 12 0.0011
440 DYSGRAPHIA 7 0.0011
441 MYOCARDIAL ISCHAEMIA 12 0.0011
442 LIPASE INCREASED 8 0.0010
443 INCONTINENCE 11 0.0010
444 PARAESTHESIA ORAL 15 0.0010
445 CONFUSIONAL STATE 168 0.0010
446 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
447 APATHY 15 0.0010
448 DRUG LEVEL INCREASED 17 0.0010
449 SPINAL OSTEOARTHRITIS 9 0.0010
450 TUMOUR LYSIS SYNDROME 9 0.0010
451 NECK PAIN 57 0.0010
452 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
453 COORDINATION ABNORMAL 14 0.0010
454 ATRIAL FLUTTER 8 0.0010
455 ANAL INCONTINENCE 9 0.0010
456 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
457 OPTIC NEURITIS 9 0.0010
458 POST PROCEDURAL INFECTION 8 0.0010
459 PNEUMONIA BACTERIAL 9 0.0010
460 CARDIOMEGALY 12 0.0010
461 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
462 GRAFT VERSUS HOST DISEASE 7 0.0010
463 DELUSION 15 0.0010
464 BLOOD CREATININE INCREASED 63 0.0010
465 DIPLOPIA 25 0.0010
466 THROAT TIGHTNESS 26 0.0010
467 BRAIN FOG 15 0.0010
468 ARTERIOSCLEROSIS 9 0.0010
469 PAIN IN JAW 27 0.0010
470 MYALGIA 161 0.0009
471 ARTHROPOD BITE 7 0.0009
472 GASTROOESOPHAGEAL REFLUX DISEASE 76 0.0009
473 LEUKOPENIA 47 0.0009
474 DEMENTIA 26 0.0009
475 JAUNDICE 25 0.0009
476 PARANOIA 16 0.0009
477 BLOOD MAGNESIUM DECREASED 8 0.0009
478 CONVULSION 53 0.0009
479 MUSCLE STRAIN 8 0.0009
480 BLOOD POTASSIUM INCREASED 15 0.0009
481 PLATELET COUNT INCREASED 12 0.0009
482 PHARYNGEAL SWELLING 9 0.0009
483 VERTIGO 56 0.0009
484 OESOPHAGITIS 10 0.0009
485 URINE OUTPUT DECREASED 8 0.0009
486 BURNING SENSATION 64 0.0009
487 DEPRESSED LEVEL OF CONSCIOUSNESS 36 0.0009
488 VENTRICULAR TACHYCARDIA 15 0.0009
489 MUSCULAR WEAKNESS 103 0.0009
490 NOCTURIA 11 0.0009
491 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
492 DENTAL CARIES 10 0.0009
493 LYMPHADENOPATHY 32 0.0009
494 VENTRICULAR FIBRILLATION 10 0.0009
495 SALIVARY HYPERSECRETION 9 0.0009
496 ANAEMIA 171 0.0009
497 BLOOD UREA INCREASED 15 0.0009
498 BLOOD GLUCOSE DECREASED 43 0.0009
499 CYANOSIS 14 0.0009
500 PANCREATITIS ACUTE 20 0.0009
501 JOINT INJURY 19 0.0009
502 ALANINE AMINOTRANSFERASE INCREASED 54 0.0009
503 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
504 TEMPERATURE INTOLERANCE 9 0.0009
505 AGITATION 64 0.0009
506 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
507 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
508 HYPERBILIRUBINAEMIA 9 0.0009
509 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
510 PARAESTHESIA 136 0.0009
511 DELIRIUM 30 0.0009
512 COMA 41 0.0009
513 ANXIETY 245 0.0009
514 HEPATIC ENCEPHALOPATHY 8 0.0009
515 CARPAL TUNNEL SYNDROME 12 0.0009
516 THERAPY INTERRUPTED 61 0.0009
517 FLANK PAIN 8 0.0009
518 DYSARTHRIA 32 0.0008
519 URINARY TRACT INFECTION 145 0.0008
520 HIATUS HERNIA 11 0.0008
521 RENAL PAIN 9 0.0008
522 ORAL PAIN 19 0.0008
523 DEVICE RELATED INFECTION 13 0.0008
524 URINARY INCONTINENCE 25 0.0008
525 BODY HEIGHT DECREASED 9 0.0008
526 MACULAR DEGENERATION 10 0.0008
527 HALLUCINATION 63 0.0008
528 THERAPY PARTIAL RESPONDER 13 0.0008
529 POST PROCEDURAL COMPLICATION 16 0.0008
530 INFLAMMATION 43 0.0008
531 ACUTE RESPIRATORY FAILURE 16 0.0008
532 ANOSMIA 12 0.0008
533 OSTEOMYELITIS 15 0.0008
534 ASPARTATE AMINOTRANSFERASE INCREASED 44 0.0008
535 TACHYCARDIA 73 0.0008
536 TOOTH FRACTURE 9 0.0008
537 SENSORY DISTURBANCE 13 0.0008
538 HAEMATOCRIT DECREASED 16 0.0008
539 HEPATIC STEATOSIS 15 0.0008
540 PLEURAL EFFUSION 49 0.0008
541 SKIN INFECTION 9 0.0008
542 DEVICE USE ISSUE 14 0.0008
543 SECRETION DISCHARGE 10 0.0008
544 BRONCHITIS 59 0.0008
545 FULL BLOOD COUNT DECREASED 16 0.0008
546 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
547 SCAB 9 0.0008
548 BONE MARROW FAILURE 16 0.0008
549 CONDITION AGGRAVATED 239 0.0008
550 PRESYNCOPE 19 0.0008
551 HYPERSENSITIVITY 145 0.0008
552 HYPONATRAEMIA 44 0.0008
553 CARDIAC DISORDER 73 0.0008
554 FUNGAL INFECTION 26 0.0008
555 PERICARDIAL EFFUSION 18 0.0008
556 HIP FRACTURE 25 0.0008
557 LUNG DISORDER 38 0.0008
558 MADAROSIS 9 0.0008
559 LUNG INFECTION 12 0.0008
560 NEUTROPENIA 105 0.0008
561 EJECTION FRACTION DECREASED 12 0.0008
562 SEPSIS 86 0.0008
563 SINUSITIS 79 0.0008
564 DYSPHAGIA 73 0.0008
565 PALPITATIONS 90 0.0008
566 BONE DISORDER 14 0.0008
567 EXOSTOSIS 7 0.0008
568 SLEEP DISORDER 54 0.0008
569 DRUG-INDUCED LIVER INJURY 24 0.0008
570 DEAFNESS 20 0.0008
571 DERMATITIS 16 0.0008
572 AGEUSIA 19 0.0008
573 MYELODYSPLASTIC SYNDROME 11 0.0008
574 DEPRESSION 173 0.0008
575 MOUTH ULCERATION 16 0.0008
576 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
577 SINUS DISORDER 15 0.0008
578 THERAPY NON-RESPONDER 34 0.0008
579 HEPATIC FUNCTION ABNORMAL 28 0.0007
580 DEFORMITY 7 0.0007
581 ANGIOEDEMA 33 0.0007
582 RASH MACULAR 26 0.0007
583 FEAR 20 0.0007
584 DYSPNOEA EXERTIONAL 28 0.0007
585 BURSITIS 9 0.0007
586 MUSCLE TIGHTNESS 12 0.0007
587 SINUS CONGESTION 10 0.0007
588 OEDEMA 40 0.0007
589 GASTRIC ULCER 14 0.0007
590 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
591 SKIN LACERATION 8 0.0007
592 MUSCULOSKELETAL DISORDER 14 0.0007
593 BRADYCARDIA 39 0.0007
594 GENERAL PHYSICAL HEALTH DETERIORATION 85 0.0007
595 HEAD DISCOMFORT 13 0.0007
596 IMPAIRED GASTRIC EMPTYING 10 0.0007
597 ANGINA PECTORIS 21 0.0007
598 BLOOD POTASSIUM DECREASED 22 0.0007
599 WOUND INFECTION 8 0.0007
600 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
601 MANIA 12 0.0007
602 OSTEOPOROSIS 30 0.0007
603 PHARYNGITIS 9 0.0007
604 DISTURBANCE IN ATTENTION 39 0.0007
605 PYREXIA 250 0.0007
606 GASTRITIS 19 0.0007
607 TOOTH DISORDER 16 0.0007
608 ARRHYTHMIA 34 0.0007
609 MASS 10 0.0007
610 HYPOAESTHESIA 107 0.0007
611 TREATMENT NONCOMPLIANCE 39 0.0007
612 BODY TEMPERATURE DECREASED 7 0.0007
613 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 39 0.0007
614 DISABILITY 14 0.0007
615 INTENTIONAL PRODUCT USE ISSUE 62 0.0007
616 DYSURIA 26 0.0007
617 BLADDER DISORDER 7 0.0007
618 SINUS TACHYCARDIA 10 0.0007
619 BLOOD BILIRUBIN INCREASED 19 0.0007
620 BONE DENSITY DECREASED 22 0.0007
621 BRONCHOSPASM 10 0.0007
622 HERPES ZOSTER 40 0.0007
623 CEREBRAL INFARCTION 17 0.0007
624 APHASIA 21 0.0007
625 LETHARGY 40 0.0007
626 CORONARY ARTERY DISEASE 21 0.0007
627 GASTROINTESTINAL DISORDER 62 0.0007
628 RASH ERYTHEMATOUS 33 0.0007
629 BLOOD SODIUM DECREASED 13 0.0007
630 ABSCESS 11 0.0007
631 FOOT FRACTURE 13 0.0007
632 BEDRIDDEN 9 0.0007
633 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
634 RENAL IMPAIRMENT 57 0.0007
635 SWOLLEN TONGUE 21 0.0007
636 PRODUCT PRESCRIBING ERROR 16 0.0007
637 QUALITY OF LIFE DECREASED 9 0.0007
638 EPISTAXIS 50 0.0007
639 ATRIAL FIBRILLATION 65 0.0007
640 ARTHRALGIA 276 0.0007
641 VIRAL INFECTION 22 0.0007
642 ARTHRITIS 52 0.0007
643 COLITIS 25 0.0007
644 RASH GENERALISED 17 0.0007
645 INFECTION 95 0.0007
646 RESPIRATORY TRACT INFECTION 17 0.0007
647 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
648 HYPOKALAEMIA 30 0.0006
649 RHINORRHOEA 42 0.0006
650 MUSCULOSKELETAL PAIN 34 0.0006
651 LACTIC ACIDOSIS 21 0.0006
652 OEDEMA PERIPHERAL 79 0.0006
653 CARDIAC FAILURE 52 0.0006
654 RHABDOMYOLYSIS 27 0.0006
655 MUSCULOSKELETAL CHEST PAIN 10 0.0006
656 FAECES DISCOLOURED 14 0.0006
657 EXTRAPYRAMIDAL DISORDER 16 0.0006
658 ILEUS 8 0.0006
659 MENTAL DISORDER 28 0.0006
660 BACTERIAL INFECTION 12 0.0006
661 PNEUMONIA ASPIRATION 16 0.0006
662 NO ADVERSE EVENT 116 0.0006
663 PRODUCT DOSE OMISSION ISSUE 188 0.0006
664 EMOTIONAL DISTRESS 77 0.0006
665 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
666 PROTEINURIA 12 0.0006
667 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
668 SURGERY 37 0.0006
669 INSOMNIA 168 0.0006
670 HEPATIC FAILURE 19 0.0006
671 SWELLING FACE 41 0.0006
672 SKIN DISORDER 21 0.0006
673 HEPATOTOXICITY 14 0.0006
674 NEUROTOXICITY 11 0.0006
675 SCIATICA 10 0.0006
676 IMPAIRED QUALITY OF LIFE 9 0.0006
677 HYPOXIA 22 0.0006
678 PALLOR 17 0.0006
679 BLISTER 35 0.0006
680 ROTATOR CUFF SYNDROME 8 0.0006
681 SKIN ULCER 16 0.0006
682 DYSSTASIA 18 0.0006
683 CHOKING 12 0.0006
684 HAEMOGLOBIN DECREASED 63 0.0006
685 NODULE 8 0.0006
686 ARTHROPATHY 34 0.0006
687 SPEECH DISORDER 32 0.0006
688 NEPHROLITHIASIS 28 0.0006
689 CARDIAC FAILURE CONGESTIVE 49 0.0006
690 SHOCK 14 0.0006
691 C-REACTIVE PROTEIN INCREASED 22 0.0006
692 PULMONARY OEDEMA 27 0.0006
693 URTICARIA 101 0.0006
694 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
695 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
696 HYPOAESTHESIA ORAL 9 0.0006
697 CYSTITIS 19 0.0006
698 PNEUMONIA 193 0.0006
699 HYPOTHYROIDISM 19 0.0006
700 METABOLIC ACIDOSIS 19 0.0006
701 THERAPEUTIC RESPONSE DECREASED 36 0.0006
702 TRANSIENT ISCHAEMIC ATTACK 20 0.0006
703 MELAENA 13 0.0006
704 BODY TEMPERATURE INCREASED 12 0.0006
705 DEPRESSED MOOD 31 0.0006
706 GASTROINTESTINAL HAEMORRHAGE 49 0.0006
707 BACK PAIN 136 0.0006
708 DEHYDRATION 78 0.0006
709 LIVER FUNCTION TEST ABNORMAL 17 0.0006
710 PAIN IN EXTREMITY 172 0.0006
711 MUSCULOSKELETAL STIFFNESS 51 0.0006
712 RENAL DISORDER 27 0.0006
713 INTERSTITIAL LUNG DISEASE 28 0.0006
714 FEELING COLD 16 0.0006
715 ORTHOSTATIC HYPOTENSION 10 0.0006
716 SEROTONIN SYNDROME 11 0.0006
717 CYTOPENIA 7 0.0006
718 HEART RATE DECREASED 20 0.0006
719 OXYGEN SATURATION DECREASED 32 0.0006
720 HYPERCALCAEMIA 7 0.0006
721 PRODUCT DOSE OMISSION 37 0.0006
722 PRODUCTIVE COUGH 27 0.0006
723 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
724 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
725 ISCHAEMIC STROKE 10 0.0006
726 HEADACHE 351 0.0006
727 INCORRECT ROUTE OF DRUG ADMINISTRATION 20 0.0006
728 PARALYSIS 8 0.0006
729 HYPOACUSIS 24 0.0006
730 HYPERTENSION 118 0.0006
731 COGNITIVE DISORDER 26 0.0006
732 DERMATITIS ALLERGIC 7 0.0006
733 MUSCLE SPASMS 102 0.0006
734 TREATMENT FAILURE 46 0.0006
735 BLOOD PRESSURE ABNORMAL 11 0.0006
736 LIMB INJURY 15 0.0006
737 DYSGEUSIA 41 0.0006
738 HYPOKINESIA 8 0.0006
739 PNEUMONITIS 15 0.0006
740 PRODUCT PRESCRIBING ISSUE 12 0.0006
741 CHEST PAIN 102 0.0006
742 RESPIRATORY FAILURE 40 0.0005
743 HYPOPHAGIA 14 0.0005
744 ACCIDENTAL OVERDOSE 20 0.0005
745 BONE PAIN 32 0.0005
746 BLOOD PRESSURE DECREASED 36 0.0005
747 PSYCHOTIC DISORDER 16 0.0005
748 DYSKINESIA 22 0.0005
749 CARDIOMYOPATHY 8 0.0005
750 DIVERTICULITIS 15 0.0005
751 INJURY 38 0.0005
752 ERYTHEMA 111 0.0005
753 SKIN HAEMORRHAGE 8 0.0005
754 SYNCOPE 54 0.0005
755 DIARRHOEA 348 0.0005
756 ASTHENIA 202 0.0005
757 SNEEZING 12 0.0005
758 RASH 232 0.0005
759 PRURITUS 204 0.0005
760 CEREBRAL HAEMORRHAGE 19 0.0005
761 INTESTINAL OBSTRUCTION 20 0.0005
762 LIVER INJURY 13 0.0005
763 INTENTIONAL DOSE OMISSION 15 0.0005
764 PAIN 323 0.0005
765 EPILEPSY 16 0.0005
766 FALL 173 0.0005
767 CHOLELITHIASIS 17 0.0005
768 HERNIA 10 0.0005
769 LIMB DISCOMFORT 16 0.0005
770 FEMUR FRACTURE 16 0.0005
771 ILLNESS 53 0.0005
772 HAEMORRHOIDS 10 0.0005
773 TREMOR 85 0.0005
774 COUGH 143 0.0005
775 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
776 BALANCE DISORDER 44 0.0005
777 GAIT INABILITY 17 0.0005
778 ABDOMINAL PAIN 118 0.0005
779 PRODUCT DISPENSING ERROR 11 0.0005
780 PNEUMOTHORAX 8 0.0005
781 MEMORY IMPAIRMENT 69 0.0005
782 HAEMOPTYSIS 14 0.0005
783 OFF LABEL USE 437 0.0005
784 GASTROENTERITIS VIRAL 9 0.0005
785 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 26 0.0005
786 FEBRILE NEUTROPENIA 33 0.0005
787 PLATELET COUNT DECREASED 53 0.0005
788 TOOTHACHE 9 0.0005
789 OROPHARYNGEAL PAIN 46 0.0005
790 CARDIAC ARREST 41 0.0005
791 CELLULITIS 25 0.0005
792 INFLUENZA 55 0.0005
793 FLUID RETENTION 25 0.0005
794 WHEEZING 29 0.0005
795 WHITE BLOOD CELL COUNT DECREASED 53 0.0005
796 CARDIOGENIC SHOCK 7 0.0005
797 METASTASES TO BONE 8 0.0005
798 CHROMATURIA 11 0.0005
799 GAIT DISTURBANCE 93 0.0005
800 DYSPNOEA 273 0.0005
801 SUICIDAL IDEATION 44 0.0005
802 URINARY RETENTION 16 0.0005
803 DYSPHONIA 28 0.0005
804 ECZEMA 25 0.0005
805 ACUTE MYOCARDIAL INFARCTION 14 0.0005
806 HEART RATE INCREASED 47 0.0005
807 FEELING HOT 29 0.0005
808 CHILLS 55 0.0005
809 LOWER LIMB FRACTURE 9 0.0005
810 RESPIRATORY DISORDER 14 0.0005
811 SEIZURE 54 0.0005
812 BONE LOSS 7 0.0005
813 RECTAL HAEMORRHAGE 20 0.0005
814 UNRESPONSIVE TO STIMULI 12 0.0005
815 HYPOTENSION 93 0.0005
816 DISEASE RECURRENCE 22 0.0005
817 STOMATITIS 28 0.0005
818 DEEP VEIN THROMBOSIS 30 0.0005
819 RASH PRURITIC 25 0.0005
820 NASAL CONGESTION 27 0.0005
821 DISCOMFORT 28 0.0005
822 JOINT STIFFNESS 12 0.0005
823 SKIN DISCOLOURATION 21 0.0005
824 PRODUCT USE IN UNAPPROVED INDICATION 113 0.0005
825 POLLAKIURIA 19 0.0005
826 METASTASES TO LIVER 8 0.0005
827 DIZZINESS 227 0.0005
828 ABNORMAL BEHAVIOUR 18 0.0005
829 COLD SWEAT 8 0.0005
830 ANKLE FRACTURE 7 0.0005
831 UPPER LIMB FRACTURE 9 0.0005
832 ACUTE MYELOID LEUKAEMIA 7 0.0004
833 BASAL CELL CARCINOMA 7 0.0004
834 GALLBLADDER DISORDER 8 0.0004
835 THIRST 8 0.0004
836 DIABETES MELLITUS 34 0.0004
837 GOUT 8 0.0004
838 TYPE 2 DIABETES MELLITUS 15 0.0004
839 BLOOD PRESSURE INCREASED 68 0.0004
840 FEEDING DISORDER 9 0.0004
841 ASCITES 13 0.0004
842 PELVIC PAIN 8 0.0004
843 CONSTIPATION 96 0.0004
844 RESTLESS LEGS SYNDROME 8 0.0004
845 SWELLING 41 0.0004
846 PERITONITIS 9 0.0004
847 TOOTH LOSS 9 0.0004
848 FATIGUE 337 0.0004
849 VOMITING 203 0.0004
850 CHEST DISCOMFORT 44 0.0004
851 LOSS OF CONSCIOUSNESS 55 0.0004
852 PERIPHERAL SWELLING 66 0.0004
853 WEIGHT DECREASED 119 0.0004
854 NAUSEA 336 0.0004
855 EATING DISORDER 9 0.0004
856 DECREASED APPETITE 98 0.0004
857 NASOPHARYNGITIS 77 0.0004
858 DIABETIC KETOACIDOSIS 10 0.0004
859 PANCREATITIS 22 0.0004
860 ADVERSE DRUG REACTION 37 0.0004
861 ILL-DEFINED DISORDER 25 0.0004
862 HYPERHIDROSIS 53 0.0004
863 RESTLESSNESS 15 0.0004
864 COVID-19 71 0.0004
865 NIGHTMARE 14 0.0004
866 NIGHT SWEATS 13 0.0004
867 THROAT IRRITATION 18 0.0004
868 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 81 0.0004
869 CYTOKINE RELEASE SYNDROME 8 0.0004
870 HEART RATE IRREGULAR 9 0.0004
871 ABDOMINAL PAIN LOWER 10 0.0004
872 HAEMATEMESIS 10 0.0004
873 WOUND 11 0.0004
874 MALAISE 172 0.0004
875 EMOTIONAL DISORDER 12 0.0004
876 PULMONARY HYPERTENSION 8 0.0004
877 DEVICE ISSUE 34 0.0004
878 PRODUCT USE ISSUE 71 0.0004
879 INTENTIONAL PRODUCT MISUSE 33 0.0004
880 CONTUSION 36 0.0004
881 MOVEMENT DISORDER 12 0.0004
882 PRURITUS GENERALISED 8 0.0004
883 PSORIATIC ARTHROPATHY 15 0.0004
884 IRRITABILITY 22 0.0004
885 FEELING ABNORMAL 87 0.0004
886 RESPIRATORY ARREST 10 0.0004
887 ABNORMAL DREAMS 10 0.0004
888 MOBILITY DECREASED 26 0.0004
889 ERUCTATION 7 0.0004
890 PULMONARY EMBOLISM 34 0.0004
891 UNEVALUABLE EVENT 27 0.0004
892 BLOOD GLUCOSE INCREASED 67 0.0004
893 SKIN EXFOLIATION 30 0.0004
894 MULTIPLE SCLEROSIS 17 0.0004
895 HAEMORRHAGE 37 0.0004
896 HEPATIC ENZYME INCREASED 24 0.0004
897 GASTRIC DISORDER 12 0.0003
898 JOINT SWELLING 42 0.0003
899 HEAD INJURY 11 0.0003
900 EXPOSURE VIA SKIN CONTACT 9 0.0003
901 DISEASE PROGRESSION 41 0.0003
902 DEVICE DISLOCATION 15 0.0003
903 MUCOSAL INFLAMMATION 9 0.0003
904 NEEDLE ISSUE 10 0.0003
905 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
906 DERMATITIS ATOPIC 18 0.0003
907 LABORATORY TEST ABNORMAL 10 0.0003
908 DRUG INEFFECTIVE 446 0.0003
909 AMNESIA 22 0.0003
910 CEREBROVASCULAR ACCIDENT 57 0.0003
911 ASTHMA 38 0.0003
912 ROAD TRAFFIC ACCIDENT 14 0.0003
913 MIGRAINE 31 0.0003
914 FLUSHING 33 0.0003
915 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
916 NEUTROPHIL COUNT DECREASED 13 0.0003
917 HOT FLUSH 24 0.0003
918 APPLICATION SITE PAIN 7 0.0003
919 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 57 0.0003
920 ABDOMINAL PAIN UPPER 65 0.0003
921 LIVER DISORDER 14 0.0003
922 DYSPEPSIA 31 0.0003
923 GLOSSODYNIA 7 0.0003
924 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
925 THERAPY CESSATION 16 0.0003
926 ACCIDENTAL EXPOSURE TO PRODUCT 32 0.0003
927 ABDOMINAL DISCOMFORT 52 0.0003
928 SKIN BURNING SENSATION 22 0.0003
929 HOSPITALISATION 47 0.0003
930 ADVERSE EVENT 28 0.0003
931 BLOOD CHOLESTEROL INCREASED 14 0.0003
932 DRY SKIN 40 0.0003
933 PAIN OF SKIN 8 0.0003
934 SUICIDE ATTEMPT 18 0.0003
935 MOOD ALTERED 8 0.0003
936 OVERDOSE 62 0.0003
937 TOXICITY TO VARIOUS AGENTS 48 0.0003
938 TARDIVE DYSKINESIA 8 0.0003
939 MYOCARDIAL INFARCTION 49 0.0003
940 RED BLOOD CELL COUNT DECREASED 8 0.0003
941 AGGRESSION 14 0.0003
942 INFLUENZA LIKE ILLNESS 23 0.0003
943 HYPERSOMNIA 8 0.0003
944 NERVOUSNESS 14 0.0003
945 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
946 FLATULENCE 15 0.0003
947 SOMNOLENCE 53 0.0003
948 WITHDRAWAL SYNDROME 11 0.0003
949 THROMBOSIS 21 0.0003
950 DRUG ADMINISTRATION ERROR 8 0.0003
951 ALOPECIA 51 0.0003
952 ABDOMINAL DISTENSION 27 0.0003
953 PRODUCT QUALITY ISSUE 35 0.0003
954 INFUSION RELATED REACTION 17 0.0003
955 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
956 COMPLETED SUICIDE 21 0.0003
957 CRYING 9 0.0002
958 RHEUMATOID ARTHRITIS 28 0.0002
959 OSTEONECROSIS 8 0.0002
960 LIP SWELLING 8 0.0002
961 PSORIASIS 30 0.0002
962 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
963 EXTRA DOSE ADMINISTERED 9 0.0002
964 INCORRECT DOSE ADMINISTERED 50 0.0002
965 PRODUCT STORAGE ERROR 19 0.0002
966 EXPIRED PRODUCT ADMINISTERED 7 0.0002
967 INJECTION SITE SWELLING 16 0.0002
968 DRUG DEPENDENCE 33 0.0002
969 PLASMA CELL MYELOMA 8 0.0002
970 WEIGHT INCREASED 45 0.0002
971 ABORTION SPONTANEOUS 8 0.0002
972 DEATH 172 0.0002
973 ACNE 15 0.0002
974 DRY MOUTH 16 0.0002
975 DEVICE BREAKAGE 8 0.0002
976 DRUG EFFECT INCOMPLETE 7 0.0002
977 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
978 SKIN IRRITATION 8 0.0002
979 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002
980 UNDERDOSE 12 0.0002
981 HAEMATOCHEZIA 9 0.0002
982 COLITIS ULCERATIVE 7 0.0002
983 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
984 INTENTIONAL OVERDOSE 10 0.0002
985 INJECTION SITE ERYTHEMA 19 0.0002
986 EXPOSURE DURING PREGNANCY 9 0.0001
987 NEOPLASM MALIGNANT 9 0.0001
988 DRUG DOSE OMISSION 21 0.0001
989 INJECTION SITE PAIN 32 0.0001
990 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
991 BREAST CANCER 8 0.0001